BNP Paribas Financial Markets’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Sell |
|
|||||
|
2025
Q1 | $4.46M | Buy |
|
|||||
|
2024
Q4 | $2.66M | Sell |
|
|||||
|
2024
Q3 | $3.05M | Buy |
|
|||||
|
2024
Q2 | $775K | Sell |
|
|||||
|
2024
Q1 | $1.43M | Sell |
|
|||||
|
2023
Q4 | $5.02M | Buy |
|
|||||
|
2023
Q3 | $2.12M | Sell |
|
|||||
|
2023
Q2 | $2.63M | Sell |
|
|||||
|
2023
Q1 | $7.12M | Buy |
|
|||||
|
2022
Q4 | $5.09M | Sell |
|
|||||
|
2022
Q3 | $3.62M | Buy |
|
|||||
|
2022
Q2 | $216K | Buy |
|
|||||
|
2022
Q1 | $223K | Sell |
|
|||||
|
2021
Q4 | $366K | Buy |
|
|||||
|
2021
Q3 | $137K | Buy |
|
|||||
|
2021
Q2 | $83.1K | Sell |
|
|||||
|
2021
Q1 | $136K | Buy |
|
|||||
|
2020
Q4 | $53.9K | Sell |
|
|||||
|
2020
Q3 | $76.4K | Buy |
|
|||||
|
2020
Q2 | $86.8K | Sell |
|
|||||
|
2020
Q1 | $313K | Buy |
|
|||||
|
2019
Q4 | $42.8K | Sell |
|
|||||
|
2019
Q3 | $81.2K | Buy |
|
|||||
|
2019
Q2 | $43.8K | Sell |
|
|||||
|
2019
Q1 | $102K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $11.8K | Hold |
|
|||||
|
2018
Q2 | $9.76K | Sell |
|
|||||
|
2018
Q1 | $42.1K | Buy |
|
|||||
|
2017
Q4 | $58.1K | Buy |
|
|||||
|
2017
Q3 | $17.6K | Sell |
|
|||||
|
2017
Q2 | $20.7K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $37.3K | Sell |
|
|||||
|
2015
Q3 | $45.7K | Buy |
|
|||||
|
2015
Q2 | $25.9K | Buy |
|